摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-苯基-2-磺酰基-3,5,6,7-四氢-4h-环戊基[4,5]噻吩并[2,3-d]嘧啶-4-酮 | 300557-77-1

中文名称
3-苯基-2-磺酰基-3,5,6,7-四氢-4h-环戊基[4,5]噻吩并[2,3-d]嘧啶-4-酮
中文别名
2-巯基-3-苯基-3,5,6,7-四氢-4H-环戊烷[4,5]噻吩并[2,3-D]吡啶-4-酮
英文名称
3-phenyl-2-thioxo-2,3,6,7-tetrahydro-1H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-one
英文别名
11-phenyl-10-sulfanylidene-7-thia-9,11-diazatricyclo[6.4.0.02,6]dodeca-1(8),2(6)-dien-12-one
3-苯基-2-磺酰基-3,5,6,7-四氢-4h-环戊基[4,5]噻吩并[2,3-d]嘧啶-4-酮化学式
CAS
300557-77-1
化学式
C15H12N2OS2
mdl
MFCD00698510
分子量
300.405
InChiKey
LLFBYHAEKFMVIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >250℃

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    20
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    92.7
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090

SDS

SDS:7c3f281976fb11122b5e9931b9d02696
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-苯基-2-磺酰基-3,5,6,7-四氢-4h-环戊基[4,5]噻吩并[2,3-d]嘧啶-4-酮potassium carbonate 作用下, 以 甲醇乙腈 为溶剂, 生成 3-phenyl-2-α-lactosylthio-2,3,6,7-tetrahydro-1H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
    参考文献:
    名称:
    Synthesis of Novel Substituted 2-Lactosylthiothieno[2,3-d]pyrimidin-4(3H)-one Derivatives
    摘要:
    The title compounds substituted 2‐lactosylthiothieno[2,3‐d]pyrimidin‐4‐ones 6 were synthesized by the glycosyl reaction and alcoholysis reaction of substituted 2‐thioxo‐thieno[2,3‐d]pyrimidin‐4‐ones 4,which is formed by the base catalytic and acetic acidify reaction of amino esters 2 with alkyl or arylisothiocyanates and hepta‐O‐acetyl‐lactosyl bromide in good yields. All of the compounds were confirmed by NMR, ESI‐MS, and elemental analysis.
    DOI:
    10.1002/jhet.1794
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Novel Substituted 2-Lactosylthiothieno[2,3-d]pyrimidin-4(3H)-one Derivatives
    摘要:
    The title compounds substituted 2‐lactosylthiothieno[2,3‐d]pyrimidin‐4‐ones 6 were synthesized by the glycosyl reaction and alcoholysis reaction of substituted 2‐thioxo‐thieno[2,3‐d]pyrimidin‐4‐ones 4,which is formed by the base catalytic and acetic acidify reaction of amino esters 2 with alkyl or arylisothiocyanates and hepta‐O‐acetyl‐lactosyl bromide in good yields. All of the compounds were confirmed by NMR, ESI‐MS, and elemental analysis.
    DOI:
    10.1002/jhet.1794
点击查看最新优质反应信息

文献信息

  • Stereoselective synthesis of (<i>E</i>)-halomethylidene[1,3]thiazolo[3,2-<i>a</i>]thieno[3,2-<i>e</i>]pyrimidinium and analogous [1,3]oxazolo[3,2-<i>a</i>]thieno[3,2-<i>e</i>]pyrimidinium halides starting from 3-<i>N</i>-substituted 2-propargylthio(oxy)thieno[2,3-<i>d</i>]pyrimidin-4-ones
    作者:Marina Slivka、Andrej Krivovjaz、Mikhailo Slivka、Vasil Lendel
    DOI:10.1515/hc-2013-0036
    日期:2013.6.1
    Abstract A convenient procedure for the stereoselective synthesis of [1,3]thiazolo[3,2-a]thieno[3,2-e]pyrimidinium halides and analogous [1,3]oxazolo[3,2-a]thieno[3,2-e]pyrimidinium halides 5 and 6 is reported. 2-Propargylthio-3-R-thieno[2,3-d]pyrimidin-4-ones and 2-propargyloxy-3-R-thieno[2,3-d]pyrimidin-4-ones were treated with bromine or iodine in AcOH to afford (E)-halomethylidene[1,3]thiazolo[3
    摘要 [1,3]噻唑并[3,2-a]噻吩并[3,2-e]嘧啶鎓卤化物和类似物[1,3]恶唑并[3,2-a]噻吩并[3]的立体选择性合成方法,2-e]嘧啶鎓卤化物 5 和 6 被报道。2-Propargylthio-3-R-thieno[2,3-d]pyrimidin-4-ones 和 2-propargyloxy-3-R-thieno[2,3-d]pyrimidin-4-ones 用溴或碘处理AcOH得到(E)-卤代亚甲基[1,3]噻唑并[3,2-a]噻吩并[3,2-e]嘧啶鎓和(E)-卤代亚甲基-[1,3]恶唑并[3,2-a]噻吩并[3,2-e]嘧啶鎓卤化物,分别。
  • Structure–activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5
    作者:Ke Wang、Jinfeng Li、Alexei Degterev、Emily Hsu、Junying Yuan、Chengye Yuan
    DOI:10.1016/j.bmcl.2006.11.056
    日期:2007.3
    Necrostatin-5 (Nec-5) is a novel potent small-molecule inhibitor of necroptosis structurally distinct from previously described Necrostatin-1 (Nec-1), and therefore, represents a new direction for the inhibition of this cellular caspase-independent necrotic cell death mechanism. Here, we describe a series of structural modifications of Nec-5 and the structure-activity relationship (SAR) of Nec-5 series in inhibiting necroptosis.
  • Synthesis of Novel Substituted 2-Lactosylthiothieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one Derivatives
    作者:Qiu-hong Dai、Kai Yan、Ming-guo Liu
    DOI:10.1002/jhet.1794
    日期:2014.9
    The title compounds substituted 2‐lactosylthiothieno[2,3‐d]pyrimidin‐4‐ones 6 were synthesized by the glycosyl reaction and alcoholysis reaction of substituted 2‐thioxo‐thieno[2,3‐d]pyrimidin‐4‐ones 4,which is formed by the base catalytic and acetic acidify reaction of amino esters 2 with alkyl or arylisothiocyanates and hepta‐O‐acetyl‐lactosyl bromide in good yields. All of the compounds were confirmed by NMR, ESI‐MS, and elemental analysis.
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶